Evidence map›Paper›PMID 40051833›Full record

ArticleUrology case reports2025

De novo small cell neuroendocrine prostate cancer: An atypical case presentation.

Yalda Rahmani, Yosra Abdul Hafez, Ammar Agha, M Zaid Jarai, Nikos Mac Millan Basiliu, Elham Mahjoor Azad, Abdulmunem Alsadi, Kais Kotiesh, Mohammad Alhamad, Fariborz Bagheri

Abstract readCase Reports
In one paragraph

Article in Urology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yalda RahmaniDubai Medical College for Girls, Dubai, United Arab Emirates.
Yosra Abdul HafezDubai Medical College for Girls, Dubai, United Arab Emirates.
Ammar AghaDepartment of Urology, Dubai Hospital, Dubai, United Arab Emirates.
M Zaid JaraiDepartment of Urology, Dubai Hospital, Dubai, United Arab Emirates.
Nikos Mac Millan BasiliuDepartment of Urology, Dubai Hospital, Dubai, United Arab Emirates.
Elham Mahjoor AzadDepartment of Family Medicine, Medcare Hospital, Dubai, United Arab Emirates.
Abdulmunem AlsadiDepartment of Urology, Dubai Hospital, Dubai, United Arab Emirates.
Kais KotieshDepartment of Urology, Dubai Hospital, Dubai, United Arab Emirates.
Mohammad AlhamadDepartment of Urology, Dubai Hospital, Dubai, United Arab Emirates.
Fariborz BagheriDepartment of Urology, Dubai Hospital, Dubai, United Arab Emirates.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Small cell neuroendocrine carcinoma comprises less than 1 % of all prostate cancers. We report a case of a 62-year-old male who presented acutely with severe lower urinary tract symptoms (LUTS), including nocturia, but with normal prostate-specific antigen (PSA) levels. A tender, stony-hard prostate on digital rectal examination (DRE) led to prostate biopsy and imaging. The biopsy confirmed neuroendocrine carcinoma, and chemotherapy was initiated. This case emphasizes the atypical presentation of neuroendocrine prostate cancer with acute, severe LUTS and rapid progression, underscoring the potential for missed diagnoses when PSA levels are normal.

Identifiers

PMID40051833
PMCPMC11883398

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.